Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 7/24/2025Kelun-Biotech Initiates Phase I Trial of SKB107
  • 7/24/2025Cascade Pharma's CS0159 Wins FDA Breakthrough For PBC
  • 7/23/2025China-Singapore Nanovaccine Prevents Cancer Recurrence in Animals
  • 7/23/2025DualityBio's DB‑1310 Earns FDA Fast‑Track for EGFR‑Mutated Lung Can...
  • 7/23/2025Qilu Initiates Global Phase III Trial of QLS31905 for Pancreatic Cance...
  • 7/23/2025Kelun‑Biotech Launches Phase I Trial of SKB107 in China to Tackle Bon...
  • 7/22/2025Livzon's Dual Inhibitor LZM‑012 Positive in Global Phase III Psoriasi...
  • 7/22/2025Cloudbreak Pharma Reports Positive Phase 2 Outcomes for CBT‑004
  • 7/22/2025Simcere Zaiming Secures U.S. FDA Approval for IND of FGFR2b-Targeted A...
  • 7/22/2025AusperBio Cleared to Begin Phase III Trial of AHB-137 for Chronic HepB...
  • 7/22/2025Huadong Subsidiary Reports Strong Phase III Results for Roflumilast Cr...
  • 7/22/2025Innovent Secures IND for Oral GLP‑1 Agonist IBI3032 as Mazdutide Hits...
  • 7/18/2025SKBio Wins Chinese Clinical Trial Approval for GBP410
  • 7/18/2025Hengrui's SHR‑A1904 Emerges as Promising New Weapon Against Advanced ...
  • 7/18/2025China Approves First Homegrown Oral Anti‑Influenza Drug by Zenshine P...
  • 7/18/2025China Greenlights New Semaglutide Indication to Combat Kidney and Card...
  • 7/18/2025China Approves Nation's First Recombinant Human Albumin Injection Deri...
  • 7/17/2025China Accepts Amgen and ONC Marketing Submission for Imdelltra in ES-S...
  • 7/16/2025AstraZeneca Secures First-Time Clinical Trial Approvals in China for F...
  • 7/16/2025Innovent Initiates Phase III Trial for IBI343 in Advanced Pancreatic C...
  • 7/15/2025China Clears IND for YolTech’s First-in-Class In Vivo Base Editing Th...
  • 7/15/2025Hengrui Prepares Chinese NDA for Kailera Drug After Phase 3 Obesity Wi...
  • 7/14/2025Shanghai Cell Therapy Unveils BZE2204: Rapid CAR‑T with Impressive Ef...
  • 7/14/2025Akeso Launches Phase II Study Combining BsAbs with Tinengotinib
  • 7/14/2025InnoCare Announces FDA Approval of Clinical Trial for BCL2 Inhibitor M...
  • 7/14/2025Ascentage's Lisaftoclax (APG‑2575) Gains NMPA Green Light for CLL/SLL
  • 7/11/2025Evopoint's CLDN18.2‑Targeting ADC XNW27011 Launches First Phase III T...
  • 7/11/2025Regenelead's KRAS-Targeted Cancer Vaccine Approved for Clinical Trials...
  • 7/11/2025BeOne's Tevimbra Wins EU Green Light for First-Line Nasopharyngeal Can...
  • 7/10/2025Henlius Wins Global Regulatory Clearance to Launch Phase 2 Trial of PD...
  • Page:14/22 Total number of articles:647: [First][<<] [12] [13] [14] [15] [16] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group